ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, AbbVie Inc. (ABBV) shows an Average True Range (ATR) of 4.15 and an Enterprise Value of 343.69B. Its average trading volume over the past 3 months is 6.3M, indicating liquidity. These fundamental metrics provide insight into ABBV's underlying financial health and market activity.
AbbVie Inc. (ABBV) technical indicators as of July 31, 2025: the SMA 20 is -0.29%, SMA 50 at 0.75%, and SMA 200 at 0.76%. The RSI 14 value is 50.4, suggesting its current momentum. These technical analysis signals help assess ABBV's price trends and potential future movements.
AbbVie Inc. (ABBV) stock performance overview as of July 31, 2025: The 52-week high is $218.66 (currently -13.42% below), and the 52-week low is $163.81 (currently 15.57% above). Over the past year, ABBV's performance is 3.92%, compared to the S&P 500's 15.22% change.
According to market data, AbbVie Inc. (ABBV) stock's recent performance metrics show that over the last month, ABBV is 1.99%, with a Year-to-Date (YTD) performance of 6.53%. Over the past year, the stock has seen a 3.92% change. These figures summarize ABBV's price movements across various periods, reflecting its historical returns.
According to current financial data, ABBV stock's P/E (TTM) ratio is 79.85, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ABBV, including P/S (5.83), P/B (235.90), and P/FCF (21.75), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.